374 related articles for article (PubMed ID: 18606861)
1. p66shc negatively regulates insulin-like growth factor I signal transduction via inhibition of p52shc binding to Src homology 2 domain-containing protein tyrosine phosphatase substrate-1 leading to impaired growth factor receptor-bound protein-2 membrane recruitment.
Xi G; Shen X; Clemmons DR
Mol Endocrinol; 2008 Sep; 22(9):2162-75. PubMed ID: 18606861
[TBL] [Abstract][Full Text] [Related]
2. Role of SHPS-1 in the regulation of insulin-like growth factor I-stimulated Shc and mitogen-activated protein kinase activation in vascular smooth muscle cells.
Ling Y; Maile LA; Lieskovska J; Badley-Clarke J; Clemmons DR
Mol Biol Cell; 2005 Jul; 16(7):3353-64. PubMed ID: 15888547
[TBL] [Abstract][Full Text] [Related]
3. Insulin-like growth factor-I-stimulated insulin receptor substrate-1 negatively regulates Src homology 2 domain-containing protein-tyrosine phosphatase substrate-1 function in vascular smooth muscle cells.
Radhakrishnan Y; Busby WH; Shen X; Maile LA; Clemmons DR
J Biol Chem; 2010 May; 285(21):15682-95. PubMed ID: 20207740
[TBL] [Abstract][Full Text] [Related]
4. p66shc inhibits insulin-like growth factor-I signaling via direct binding to Src through its polyproline and Src homology 2 domains, resulting in impairment of Src kinase activation.
Xi G; Shen X; Clemmons DR
J Biol Chem; 2010 Mar; 285(10):6937-51. PubMed ID: 20048152
[TBL] [Abstract][Full Text] [Related]
5. The role of Src kinase in insulin-like growth factor-dependent mitogenic signaling in vascular smooth muscle cells.
Lieskovska J; Ling Y; Badley-Clarke J; Clemmons DR
J Biol Chem; 2006 Sep; 281(35):25041-53. PubMed ID: 16825188
[TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor-I stimulates Shc-dependent phosphatidylinositol 3-kinase activation via Grb2-associated p85 in vascular smooth muscle cells.
Radhakrishnan Y; Maile LA; Ling Y; Graves LM; Clemmons DR
J Biol Chem; 2008 Jun; 283(24):16320-31. PubMed ID: 18420583
[TBL] [Abstract][Full Text] [Related]
7. The association between integrin-associated protein and SHPS-1 regulates insulin-like growth factor-I receptor signaling in vascular smooth muscle cells.
Maile LA; Badley-Clarke J; Clemmons DR
Mol Biol Cell; 2003 Sep; 14(9):3519-28. PubMed ID: 12972543
[TBL] [Abstract][Full Text] [Related]
8. Hyperglycemia-induced p66shc inhibits insulin-like growth factor I-dependent cell survival via impairment of Src kinase-mediated phosphoinositide-3 kinase/AKT activation in vascular smooth muscle cells.
Xi G; Shen X; Radhakrishnan Y; Maile L; Clemmons D
Endocrinology; 2010 Aug; 151(8):3611-23. PubMed ID: 20534722
[TBL] [Abstract][Full Text] [Related]
9. Opposite effects of the p52shc/p46shc and p66shc splicing isoforms on the EGF receptor-MAP kinase-fos signalling pathway.
Migliaccio E; Mele S; Salcini AE; Pelicci G; Lai KM; Superti-Furga G; Pawson T; Di Fiore PP; Lanfrancone L; Pelicci PG
EMBO J; 1997 Feb; 16(4):706-16. PubMed ID: 9049300
[TBL] [Abstract][Full Text] [Related]
10. PDK1 recruitment to the SHPS-1 signaling complex enhances insulin-like growth factor-i-stimulated AKT activation and vascular smooth muscle cell survival.
Shen X; Xi G; Radhakrishnan Y; Clemmons DR
J Biol Chem; 2010 Sep; 285(38):29416-24. PubMed ID: 20643654
[TBL] [Abstract][Full Text] [Related]
11. Insulin receptor substrate 2 and Shc play different roles in insulin-like growth factor I signaling.
Kim B; Cheng HL; Margolis B; Feldman EL
J Biol Chem; 1998 Dec; 273(51):34543-50. PubMed ID: 9852124
[TBL] [Abstract][Full Text] [Related]
12. Expression of the human beta3 integrin subunit in mouse smooth muscle cells enhances IGF-I-stimulated signaling and proliferation.
Xi G; Maile LA; Yoo SE; Clemmons DR
J Cell Physiol; 2008 Feb; 214(2):306-15. PubMed ID: 17607710
[TBL] [Abstract][Full Text] [Related]
13. Identification of novel SHPS-1-associated proteins and their roles in regulation of insulin-like growth factor-dependent responses in vascular smooth muscle cells.
Shen X; Xi G; Radhakrishnan Y; Clemmons DR
Mol Cell Proteomics; 2009 Jul; 8(7):1539-51. PubMed ID: 19299420
[TBL] [Abstract][Full Text] [Related]
14. Non-canonical dynamic mechanisms of interaction between the p66Shc protein and Met receptor.
Landry M; Pomerleau V; Saucier C
Biochem J; 2016 Jun; 473(11):1617-27. PubMed ID: 27048591
[TBL] [Abstract][Full Text] [Related]
15. Recruitment of Nox4 to a plasma membrane scaffold is required for localized reactive oxygen species generation and sustained Src activation in response to insulin-like growth factor-I.
Xi G; Shen XC; Wai C; Clemmons DR
J Biol Chem; 2013 May; 288(22):15641-53. PubMed ID: 23612968
[TBL] [Abstract][Full Text] [Related]
16. EphB1 recruits c-Src and p52Shc to activate MAPK/ERK and promote chemotaxis.
Vindis C; Cerretti DP; Daniel TO; Huynh-Do U
J Cell Biol; 2003 Aug; 162(4):661-71. PubMed ID: 12925710
[TBL] [Abstract][Full Text] [Related]
17. Stimulation of pancreatic beta-cell proliferation by growth hormone is glucose-dependent: signal transduction via janus kinase 2 (JAK2)/signal transducer and activator of transcription 5 (STAT5) with no crosstalk to insulin receptor substrate-mediated mitogenic signalling.
Cousin SP; Hügl SR; Myers MG; White MF; Reifel-Miller A; Rhodes CJ
Biochem J; 1999 Dec; 344 Pt 3(Pt 3):649-58. PubMed ID: 10585851
[TBL] [Abstract][Full Text] [Related]
18. Tyrosine phosphorylation-dependent and -independent role of Shc in the regulation of IGF-1-induced mitogenesis and glycogen synthesis.
Sasaoka T; Ishiki M; Wada T; Hori H; Hirai H; Haruta T; Ishihara H; Kobayashi M
Endocrinology; 2001 Dec; 142(12):5226-35. PubMed ID: 11713219
[TBL] [Abstract][Full Text] [Related]
19. Recruitment of Pyk2 to SHPS-1 signaling complex is required for IGF-I-dependent mitogenic signaling in vascular smooth muscle cells.
Shen X; Xi G; Radhakrishnan Y; Clemmons DR
Cell Mol Life Sci; 2010 Nov; 67(22):3893-903. PubMed ID: 20521079
[TBL] [Abstract][Full Text] [Related]
20. Dual role of SRC homology domain 2-containing inositol phosphatase 2 in the regulation of platelet-derived growth factor and insulin-like growth factor I signaling in rat vascular smooth muscle cells.
Sasaoka T; Kikuchi K; Wada T; Sato A; Hori H; Murakami S; Fukui K; Ishihara H; Aota R; Kimura I; Kobayashi M
Endocrinology; 2003 Sep; 144(9):4204-14. PubMed ID: 12933696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
